AB Intl Health Care I GBP
HealthcarePricing frequency
Daily
Dealing cut off time
17:00
Type
SICAV
Yield
–
NAV
£22.38
Income frequency
-
Ongoing charge
1.13%
Latest actual NAV date
25-04-2025
ISIN
LU1934454544
UCITS
Yes
This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment
Before investing please read:
Growth of 10k
Asset allocation
Top 10 holdings
Holdings 31/03/2025 | % of assets |
---|---|
Eli Lilly and Co | 9.46 |
UnitedHealth Group Inc | 8.36 |
Johnson & Johnson | 7.41 |
Roche Holding AG | 6.64 |
Gilead Sciences Inc | 5.64 |
Cencora Inc | 4.47 |
Intuitive Surgical Inc | 4.16 |
Vertex Pharmaceuticals Inc | 4.05 |
Merck & Co Inc | 3.94 |
Novo Nordisk AS Class B | 3.81 |
Investment objective
The Portfolio seeks to increase the value of investment over time through capital growth. Under normal market conditions, the Portfolio typically invests at least 80%, and not less than two thirds, of its assets in equity securities of companies in health care and health care-related industries. These companies may be located anywhere in the world, including Emerging Markets. The Portfolio may be exposed to any currency.
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.
Morningstar ratingTM
Morningstar sustainability ratingTM
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.